Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02326675 · ClinicalTrials.gov registry record · NA

Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant

A NA study, sponsored by University of Florida.

Terminated
Registry status
NA
Development phase
29
Enrollment target

NCT02326675: Clinical Trial NA study, sponsored by University of Florida.

NCT02326675 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02326675, a NA study, was terminated before completion, sponsored by University of Florida.

TERMINATED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

Oral mucositis is a common complication of cancer therapy. Mucositis results from damage to the mucosal epithelium after delivery of chemotherapy or radiation treatments designed to treat the cancer. A number of treatment factors have been shown to influence the incidence and severity of mucositis, including chemotherapy type and dosage. High-dose chemotherapy before stem cell transplantation can cause severe oral mucositis and is often the side effect that patients find the most difficult to endure. Cryotherapy, keeping ice chips in the mouth during chemotherapy infusion, has been shown to prevent or alleviate mucositis caused by high-dose melphalan alone or given in combinations used in pre-transplant conditioning. One other drug notorious for causing severe mucositis is etoposide (VP-16). The specific aims of the study are: 1) to assess tolerability of cryotherapy given during chemotherapy administration; 2) to determine the efficacy of cryotherapy in reducing etoposide-induced mucositis.

Interventions

  • OTHER Ice
  • OTHER Normal Saline Solution

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2015-03
Est. Completion 2017-12
Phase NA
University of Florida

1,106 total trials

Why NCT02326675 stopped before completion

NCT02326675 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Ice is the first listed.

NCT02326675 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02326675 about?

NCT02326675 is a clinical study titled "Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant". Oral mucositis is a common complication of cancer therapy. Mucositis results from damage to the mucosal epithelium after delivery of chemotherapy or radiation treatments designed to treat the cancer. A number of treatment factors have been shown to influence the incidence and severity of mucositis, ...

What is the current status of trial NCT02326675?

This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2015-03. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02326675?

The interventions under investigation include: Ice (OTHER), Normal Saline Solution (OTHER).

Who is sponsoring clinical trial NCT02326675?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02326675's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02326675, the US trial registry maintained by the National Library of Medicine. NCT02326675 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.